Why do I have stomach pain with Wegovy?

Translate to Spanish or other 102 languages!

Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. Image for illustration purposes
Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. Image for illustration purposes
- Advertisement -

Medical News Today

Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. This discomfort usually occurs because the medication slows down gastric emptying, which means food stays in your stomach longer than usual. 

Most people who experience this side effect notice it during the first few weeks of treatment or immediately after a healthcare professional increases their dose.

- Advertisement -

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/drugs-wegovy-stomach-pain?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-03-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#How-to-get-rid-of-Wegovy-stomach-pain

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Brownsville’s 2nd Annual Fall Fest and Health Fair, Oct. 24th

DHR Health Brownsville is bringing families together for a day of wellness and fun at its 2nd Annual Fall Fest and Health Fair. The event will be held from 8 a.m. to noon on October 24, 2026, at the DHR Health Brownsville Hospital, at 4750 North Expressway 77, in north Brownsville. The event is free and open to the public.

The Impact of Physical Activity on Parkinson’s Decline

For 68-year-old Robert Kennedy, a retired Florida Power and Light foreman, the secret to managing his Parkinson symptoms is movement.

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment 

The U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.
- Advertisement -